Biovian signs an agreement about early-stage development and manufacturing of a COVID-19 vaccine candidate.
Biovian has signed an agreement with a European biopharmaceutical company for contract development and manufacturing of a COVID-19 vaccine. The contract covers the early-stage development and purification of the biological vaccine candidate.
